Mason v. Texaco, Inc.

741 F. Supp. 1472, 31 Fed. R. Serv. 97, 1990 U.S. Dist. LEXIS 8300, 1990 WL 94580
CourtDistrict Court, D. Kansas
DecidedJuly 6, 1990
DocketCiv. A. 78-1337
StatusPublished
Cited by43 cases

This text of 741 F. Supp. 1472 (Mason v. Texaco, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mason v. Texaco, Inc., 741 F. Supp. 1472, 31 Fed. R. Serv. 97, 1990 U.S. Dist. LEXIS 8300, 1990 WL 94580 (D. Kan. 1990).

Opinion

*1477 OPINION AND ORDER DENYING DEFENDANT’S POST TRIAL MOTION

THEIS, District Judge.

This matter is before the court on the motion of defendant Texaco for judgment notwithstanding the verdict, or alternatively, for a new trial. After the reversal and remand by the Tenth Circuit, 862 F.2d 242, the second trial in this case commenced on September 27, 1989 and lasted through closing arguments on January 3, 1990. The jury returned a verdict for plaintiff, finding defendant 100% liable for compensatory damages totaling $9,025,000 and punitive damages in the amount of $25,000,-000.

Although the facts of this case have been reported in the Tenth Circuit’s remand order and in a Kansas Supreme Court opinion upon certified question, Mason v. Gerin Corp., 231 Kan. 718, 647 P.2d 1340 (1982), the court provides a brief background here. In September, 1977 Otis Mason was diagnosed with acute myelocytic leukemia while serving in the United States Coast Guard at Yorktown, Virginia. In an attempt to ascertain the cause of Mason's leukemia, his treating and diagnosing physician learned that Mason had possibly been exposed to the chemical benzene while instructing students in the use of a motor oil test kit. Mason filed suit in 1978 against the immediate supplier of the test kit, alleging, inter alia, failure to warn of the carcinogenic danger of benzene. Otis Mason died from leukemia on December 10, 1979, and his widow Diana was substituted as plaintiff in the survival action. By two amended complaints filed in 1980, Mason added various other distributors and two manufacturers of the product, including Texaco, Inc. At this second trial, only Texaco remains as a named defendant.

Defendant raises a number of factual and procedural challenges that are claimed to require a judgment notwithstanding the verdict or a new trial. It is well settled that the “district court has broad discretion in deciding whether to grant a motion for a new trial.” Patty Precision Prods. Co. v. Brown & Sharpe Mfg., 846 F.2d 1247, 1251 (10th Cir.1988); Royal College Shop v. Northern Ins. Co. of New York, 895 F.2d 670, 677 (10th Cir.1990). In reviewing a motion for judgment notwithstanding a *1478 verdict, the court applies the same standard governing directed verdicts. Hurd v. American Hoist & Derrick Co., 734 F.2d 495, 498 (10th Cir.1984). It is not the function of the court to weigh the evidence or make credibility determinations. Id. at 499. Rather, “the trial court must view the evidence most favorably to the party against whom the motion is made, and give that party the benefit of all reasonable inferences.” Id. at 498. Thus, the court may grant a JNOV motion “only if the evidence points but one way and is susceptible to no reasonable inferences which may support the opposing party’s position.” Q.E.R., Inc. v. Hickerson, 880 F.2d 1178, 1180 (10th Cir.1989).

The court will first address those issues raised by defendant which, if meritorious, would entitle it to a grant of JNOV, and will then address the procedural challenges going to the propriety of a new trial.

I. Causation in Fact

A. Cause of Leukemia

As a threshold question, the special verdict form asked the jury to determine whether Mason’s leukemia had been caused by exposure to benzene. Defendant challenges the jury’s affirmative answer on this issue, arguing that Mason’s exposures to benzene and his clinical diagnosis by the treating physicians did not support an inference of causation.

The court would be able to accept defendant’s contentions only by ignoring the testimony both of Mason’s treating physicians and of the expert epidemiologists called by plaintiff. Basing their opinions largely on the dose and duration of dose of benzene to which Mason had been exposed while at Yorktown, these witnesses concluded that Mason’s leukemia had been caused by benzene. Because no clinical test can directly and conclusively establish a link between a given case of leukemia and benzene, Mason’s medical diagnosis provided only limited evidence of benzene-induced leukemia. However, Dr. Reid — the Coast Guard physician who first diagnosed Mason’s leukemia — testified that acute myelocytic leukemia is one of the most common forms of leukemia associated with benzene, and that this fact aided his swift identification of the causative agent in Mason’s case. Tr. Vol. 6, at 513. 1

The court is unaware of any authority that would authorize it to reject out of hand the opinions of Mason’s treating physicians and of plaintiff’s experts. As a basis for rejecting the conclusions of these witnesses, defendant refers the court only to the contrary interpretation of the evidence given by defendant’s experts. The proper deference to be given the jury’s resolution of these conflicting opinions, however, was aptly stated by the court in Ferebee v. Chevron Chem. Co., 736 F.2d 1529 (D.C.Cir.), cert. denied, 469 U.S. 1062, 105 S.Ct. 545, 83 L.Ed.2d 432 (1984):

Judges, both trial and appellate, have no special competence to resolve the complex and refractory causal issues raised by the attempt to link low-level exposure to toxic chemicals with human disease. On questions such as these, which stand at the frontier of current medical and epidemiological inquiry, if experts are willing to testify that such a link exists, it is for the jury to decide whether to credit such testimony.

Id. at 1554; see also Wilson v. Merrell Dow Pharmaceuticals, Inc., 893 F.2d 1149, 1155 (10th Cir.1990) (jury alone has the power to weigh and assess credibility of expert testimony on causation and judges will not retry facts); Graham v. Wyeth Laboratories, 906 F.2d 1399, 1404 (10th Cir.1990); McMahon v. Eli Lilly & Co., 774 F.2d 830, 834-35 (7th Cir.1985). It must also be borne in mind that the jury’s finding, and this court’s review, is governed by a standard of legal sufficiency, rather than scientific certainty. Wells v. Ortho Pharmaceutical Corp., 788 F.2d 741, 745 (11th Cir.), cert. denied, 479 U.S. 950, 107 S.Ct. 437, 93 L.Ed.2d 386 (1986). Considering the substantial expert testimony based upon the evidence, the court finds defen *1479 dant’s argument to be meritless. Defendant had ample opportunity to develop its own experts’ testimony and to test the conclusions of plaintiffs witnesses through cross examination. The jury’s finding will not be disturbed.

B. Exposure to Texaco’s Benzene

Defendant also challenges the jury’s finding that the benzene causing Mason’s leukemia was manufactured by Texaco. In a civil case such as this, product identification need only be proven by a preponderance of the evidence. McMahon, 774 F.2d at 834. Additionally, under Kansas law, a defendant who seeks to reduce his fault by comparing it to the fault of an absent party has the burden of proving the other party’s fault by a preponderance of the evidence. McGraw v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rickicki v. Borden Chem.
2018 NY Slip Op 1829 (Appellate Division of the Supreme Court of New York, 2018)
Hernandez v. Amcord, Inc.
215 Cal. App. 4th 659 (California Court of Appeal, 2013)
Dean v. United States
92 Fed. Cl. 133 (Federal Claims, 2010)
Aumand et al. v. DHMC
2009 DNH 061 (D. New Hampshire, 2009)
Aumand v. Dartmouth Hitchcock Medical Center
611 F. Supp. 2d 78 (D. New Hampshire, 2009)
Barnett v. Merck & Co.
438 F. Supp. 2d 664 (E.D. Louisiana, 2006)
In Re Vioxx Products Liability Litigation
438 F. Supp. 2d 664 (E.D. Louisiana, 2006)
Kelvin Manbodh Asbestos Litigation Series v. Hess Oil Virgin Islands Corp.
47 V.I. 215 (Superior Court of The Virgin Islands, 2005)
Morin v. United States
534 F. Supp. 2d 1179 (D. Nevada, 2005)
Burton v. R.J. Reynolds Tobacco Co.
397 F.3d 906 (Tenth Circuit, 2005)
Miller v. Pfizer Inc.(Roerig Division)
196 F. Supp. 2d 1095 (D. Kansas, 2002)
Ralston v. Smith & Nephew Richards, Inc.
275 F.3d 965 (Tenth Circuit, 2001)
Magistrini v. One Hour Martinizing Dry Cleaning
109 F. Supp. 2d 306 (D. New Jersey, 2000)
Sutera v. Perrier Group of America, Inc.
986 F. Supp. 655 (D. Massachusetts, 1997)
Lakin v. Senco Products, Inc.
925 P.2d 107 (Court of Appeals of Oregon, 1996)
Mehlman v. Mobil Oil Corp.
676 A.2d 1143 (New Jersey Superior Court App Division, 1996)
Luthi v. Owens-Corning Fiberglass Corp.
672 So. 2d 650 (District Court of Appeal of Florida, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
741 F. Supp. 1472, 31 Fed. R. Serv. 97, 1990 U.S. Dist. LEXIS 8300, 1990 WL 94580, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mason-v-texaco-inc-ksd-1990.